Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.40 |
| ▸ | CES2 | O00748 | 2/20 | 0.40 |
| ▸ | CES1 | P23141 | 2/20 | 0.40 |
| ▸ | FAAH | O00519 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 2/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.35 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.35 |
| ▸ | CETP | P11597 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6222318 | 0.93 | CNR2 (0.39) | MEN1KMT2AEPHX2CES2CES1 | |
| SCHEMBL6222330 | 0.93 | CNR2 (0.39) | MEN1KMT2AEPHX2CES2CES1 | |
| SCHEMBL2374494 | 0.92 | MEN1 (0.41) | MEN1KMT2AEPHX2CES2CES1 | |
| SCHEMBL2293072 | 0.85 | FABP3 (0.44) | MEN1KMT2ACES2CES1ALDH1A1 | |
| SCHEMBL2293061 | 0.85 | FABP3 (0.44) | MEN1KMT2ACES2CES1ALDH1A1 | |
| SCHEMBL916238 | 0.81 | MEN1 (0.43) | MEN1KMT2AEPHX2CES2CES1 | |
| SCHEMBL7052060 | 0.81 | EPHX2 (0.44) | MEN1KMT2AEPHX2CES2CES1 | |
| SCHEMBL1992846 | 0.81 | EPHX2 (0.44) | MEN1KMT2AEPHX2CES2CES1 | |
| SCHEMBL30363228 | 0.81 | MEN1 (0.43) | MEN1KMT2AEPHX2CES2CES1 | |
| SCHEMBL916235 | 0.81 | MEN1 (0.43) | MEN1KMT2AEPHX2CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1734079-B1 | SINGLE-COMPONENT CURABLE COMPOSITION | KANEKA CORP (JP) | 2016-01-20 | — | — | EP | disclosed |
| EP-2366733-B1 | Curable composition improved in curability and storage stability | KANEKA CORP (JP) | 2014-10-22 | — | — | EP | disclosed |
| EP-1930375-B1 | CURABLE COMPOSITION IMPROVED IN CURABILITY AND ADHESIVENESS | KANEKA CORP (JP) | 2012-07-04 | — | — | EP | disclosed |
| EP-2366733-A2 | Curable composition improved in curability and storage stability | KANEKA CORPORATION (JP) | 2011-09-21 | — | — | EP | disclosed |
| EP-1942153-B1 | CURABLE COMPOSITION IMPROVED IN CURABILITY AND STORAGE STABILITY | KANEKA CORP (JP) | 2010-11-17 | — | — | EP | disclosed |
| US-20090281253-A1 | CURABLE COMPOSITION IMPROVED IN CURABILITY AND STORAGE STABILITY | KANEKA CORPORATION (JP) | 2009-11-12 | — | — | US | disclosed |
| US-20080269405-A1 | Single-Component Curable Composition | KANEKA CORPORATION (JP) | 2008-10-30 | — | — | US | disclosed |
| EP-1942153-A1 | CURABLE COMPOSITION IMPROVED IN CURABILITY AND STORAGE STABILITY | Kaneka Corporation (JP) | 2008-07-09 | — | — | EP | disclosed |
| EP-1930375-A1 | CURABLE COMPOSITION IMPROVED IN CURABILITY AND ADHESIVENESS | Kaneka Corporation (JP) | 2008-06-11 | — | — | EP | disclosed |
| US-20080021140-A1 | Curable Composition | KANEKA CORPORATION (JP) | 2008-01-24 | — | — | US | disclosed |
| US-20070203297-A1 | Curable Composition | KANEKA CORPORATION | 2007-08-30 | — | — | US | disclosed |
| EP-1736511-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2006-12-27 | — | — | EP | disclosed |
| EP-1734079-A1 | SINGLE-COMPONENT CURABLE COMPOSITION | Kaneka Corporation (JP) | 2006-12-20 | — | — | EP | disclosed |
| EP-1731574-A1 | SINGLE-COMPONENT CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2006-12-13 | — | — | EP | disclosed |
| EP-1731573-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2006-12-13 | — | — | EP | disclosed |